443 related items for PubMed ID: 17301297
1. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
[Abstract] [Full Text] [Related]
2. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
[Abstract] [Full Text] [Related]
3. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec 17; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
4. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Hashino K, Ishii M, Iemura M, Akagi T, Kato H.
Pediatr Int; 2001 Jun 17; 43(3):211-7. PubMed ID: 11380911
[Abstract] [Full Text] [Related]
5. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb 17; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
6. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP.
N Engl J Med; 1991 Jun 06; 324(23):1633-9. PubMed ID: 1709446
[Abstract] [Full Text] [Related]
7. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
Platt B, Belarski E, Manaloor J, Ofner S, Carroll AE, John CC, Wood JB.
JAMA Netw Open; 2020 Jan 03; 3(1):e1918565. PubMed ID: 31899532
[Abstract] [Full Text] [Related]
8. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A, RAISE study group investigators.
Lancet; 2012 Apr 28; 379(9826):1613-20. PubMed ID: 22405251
[Abstract] [Full Text] [Related]
9. Treatment of Kawasaki disease.
Taddio A, Rosé CD.
N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
[No Abstract] [Full Text] [Related]
10. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
Pediatrics; 2012 Jan 28; 129(1):e17-23. PubMed ID: 22144699
[Abstract] [Full Text] [Related]
11. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
Wright DA, Newburger JW, Baker A, Sundel RP.
J Pediatr; 1996 Jan 28; 128(1):146-9. PubMed ID: 8551407
[Abstract] [Full Text] [Related]
12. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
Sundel RP, Baker AL, Fulton DR, Newburger JW.
J Pediatr; 2003 Jun 28; 142(6):611-6. PubMed ID: 12838187
[Abstract] [Full Text] [Related]
13. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 28; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
14. Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial.
Wu Y, Hu L, Xie X, Li W, Wang Y, Zhang L, Huang P, Li F, Li J, Xia S, Yuan J, Li M, Wang Z, Zhang X.
Am Heart J; 2024 Jul 28; 273():1-9. PubMed ID: 38508571
[Abstract] [Full Text] [Related]
15. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
Hung JJ, Chiu CH.
Ann Trop Paediatr; 2004 Mar 28; 24(1):89-93. PubMed ID: 15005973
[Abstract] [Full Text] [Related]
16. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 28; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
17. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Oct 28; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
18. Revisiting steroids in the primary treatment of acute Kawasaki disease.
Burns JC.
J Pediatr; 2006 Sep 28; 149(3):291-2. PubMed ID: 16939734
[No Abstract] [Full Text] [Related]
19. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K.
Eur J Pediatr; 1994 Sep 28; 153(9):663-7. PubMed ID: 7957426
[Abstract] [Full Text] [Related]
20. Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
Wallace CA, French JW, Kahn SJ, Sherry DD.
Pediatrics; 2000 Jun 28; 105(6):E78. PubMed ID: 10835091
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
